Abstract Details

Title Patient-reported outcome (PRO) measures used in secondary-progressive multiple sclerosis (SPMS) studies: A Systematic Review

Topic Multiple Sclerosis

Presentation(s) (-)

Poster/Presentation
Number 215

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
PRESENTER	No disclosure on file
Crystal Watson (Atara Biotherapeutics)	Ms. Watson has received personal compensation for serving as an employee of Atara Biotherapeutics. Ms. Watson has received stock or an ownership interest from Atara Biotherapeutics.
David A. Grimes, MD	No disclosure on file

��ɫ��